# A Phase IIa Study Investigating the Tolerance, Efficacy and Safety of HSK3486

> **NCT03698617** · PHASE2 · COMPLETED · sponsor: **Sichuan Haisco Pharmaceutical Group Co., Ltd** · enrollment: 114 (actual)

## Conditions studied

- Induction of General Anaesthesia

## Interventions

- **DRUG:** HSK3486
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT03698617
- **Lead sponsor:** Sichuan Haisco Pharmaceutical Group Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-06
- **Primary completion:** 2018-06-29
- **Final completion:** 2018-07-18
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2018-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03698617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03698617, "A Phase IIa Study Investigating the Tolerance, Efficacy and Safety of HSK3486". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03698617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*